| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 02/16/2006 | CA2571407A1 Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 02/15/2006 | EP1626041A2 New materials useful as electolytic solutes |
| 02/15/2006 | EP1010423B1 Oral pharmaceutical preparation comprising an antiulcer benzimidazole derivative, and process for its production |
| 02/15/2006 | CN1735593A Novel CB1 receptour inverse agonists |
| 02/15/2006 | CN1735409A Imidazol derivatives having affinity for alpha 2 receptors activity |
| 02/15/2006 | CN1733757A Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/15/2006 | CN1241916C Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/14/2006 | US6998414 Substituted arylamides as IP antagonists |
| 02/14/2006 | US6998368 Wear resistance; oil additive |
| 02/14/2006 | US6998115 Biodegradable and biocompatible and may be used in a variety of drug delivery systems; suited for the delivery of polynucleotides |
| 02/14/2006 | US6997961 N-heteroarylmethyl-m-phenylenediamine derivatives-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 02/14/2006 | CA2363145C Oxamic acids and derivatives as thyroid receptor ligands |
| 02/14/2006 | CA2248598C Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| 02/09/2006 | WO2006014134A1 Novel piperidine derivative for the treatment of depression |
| 02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/09/2006 | US20060030716 Oxidation, nitration, carboxylation catalysts; 6-carbonyloxy-1,3,5-triazine-2,4-dione derivatives |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030611 Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/09/2006 | US20060026776 Method of dyeing keratin-containing fibres |
| 02/09/2006 | CA2576073A1 Novel piperidine derivative for the treatment of depression |
| 02/08/2006 | EP1622894A1 Antitumoral antiadrogenic pyrrolidines |
| 02/08/2006 | EP1622878A2 Compounds, compositions and methods |
| 02/08/2006 | EP1622877A1 Method for the production of ionic liquids containing alkyl sulphate and functionalised alkyl sulphate-anions |
| 02/08/2006 | EP1622870A2 Glutaminyl based dp iv-inhibitors |
| 02/08/2006 | EP1622611A1 Imidazolin-2-ylaminophenyl amides as ip antagonists |
| 02/08/2006 | EP1622608A2 Compositions and methods for treating cancer |
| 02/08/2006 | EP1404696B1 Activators for oligonucleotide synthesis |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1235776B1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
| 02/08/2006 | CN1240708C New derivatives of erythromycin, process for making them and use as medicaments |
| 02/08/2006 | CN1240687C 2-(thio)-4,5-imidazoline diketone compound with herbicidal activity |
| 02/07/2006 | US6995294 attaching promoters comprising sulfur compouds to solid catalyst support selected form polystyrene, zeolites or silica; condensation of phenols and acetone to 4,4'-isopropylidenediphenol; catalysts selectivity |
| 02/07/2006 | US6995269 Guanidinobenzamides |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | US6995164 Methods of treating tumors |
| 02/07/2006 | CA2262454C Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha. |
| 02/02/2006 | WO2006012513A2 High stability diionic liquid salts |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 02/02/2006 | US20060025598 High stability diionic liquid salts |
| 02/02/2006 | US20060025596 Method for deuteration or tritiation of heterocyclic ring |
| 02/02/2006 | US20060025589 2-Thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
| 02/02/2006 | US20060025465 Process for preparing substituted imidazole derivates and intermediates used in the process |
| 02/02/2006 | US20060025463 Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases |
| 02/02/2006 | US20060025425 Benzimidazole and pyridylimidazole derivatives |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | DE102004033021A1 Liquid pressure transmitting medium, useful in hydraulic component or machines, comprises ionic liquid as pressure transmitting medium |
| 02/02/2006 | CA2574460A1 High stability diionic liquid salts |
| 02/01/2006 | EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/01/2006 | EP1620440A1 Synthesis of substituted heterocyclic compounds |
| 02/01/2006 | EP1620422A2 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 02/01/2006 | EP1620412A2 Heterocyclic compounds and hydro isomers thereof |
| 02/01/2006 | EP1620406A2 1,2-diarylimidazoles useful as inhibitors of cox |
| 02/01/2006 | EP1620092A2 Compounds, compositions, and methods |
| 02/01/2006 | EP1620091A2 Inhibitors of glutaminyl cyclase |
| 02/01/2006 | EP1620089A1 Therapeutic and prophylactic compositions and uses therefor |
| 02/01/2006 | EP1620082A2 Medical use of inhibitors of glutaminyl and glutamate cyclases |
| 02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 02/01/2006 | EP1472232A4 Processes for preparing imidazole derivatives and salts thereof |
| 02/01/2006 | EP1463707A4 A group of novel anti-cancer compounds with specific structure |
| 02/01/2006 | CN1727340A Temozolomide 8-carboxylic ester, and combination |
| 02/01/2006 | CN1727336A Compound composition prepared in alkylimidazolidone (meth)acrylates solution |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 02/01/2006 | CN1239467C Primary intermediates for oxidative coloration of hair |
| 01/31/2006 | USRE38962 Diphenyl-triazole derivatives and their use as anti-gestative immuno-suppressant and anti-tumoral agents |
| 01/31/2006 | US6992097 such as methyl-1-{2-[4-((2R)-2-{2-[(tert-butoxy)carbonylamino]-2-methylpropanoylamino}-3-indol-3-ylpropanoylamino)imidazolyl]-2-phenylacetyl}pyrrolidine-2-carboxylate |
| 01/31/2006 | US6992079 Antiproliferative agent |
| 01/31/2006 | US6992076 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals |
| 01/26/2006 | WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/26/2006 | WO2006009431A1 Process for the preparation of an (hetero)arylamine |
| 01/26/2006 | WO2006007912A1 Method for producing onium salts with a low chloride content |
| 01/26/2006 | WO2005105766A3 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them |
| 01/26/2006 | WO2005077463A3 Ligand for a monoamine receptor or transporter for treating addiction or dependence |
| 01/26/2006 | WO2001085170A9 Peptide deformylase inhibitors |
| 01/26/2006 | US20060020009 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060019994 I-sulphonlyl piperidine derivatives |
| 01/26/2006 | US20060019565 Method for delivering biologically active substnces |
| 01/26/2006 | US20060016023 Novel m-phenylenediamine derivatives as coupler components for the colouring of keratin fibres |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/26/2006 | CA2573746A1 Process for the preparation of onium salts having a low chloride content |
| 01/26/2006 | CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 01/25/2006 | EP1618380A2 N epsilon AND/OR N alpha DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH (M(OH2)3(CO)3)+ BY FAC COORDINATION |
| 01/25/2006 | EP1618230A2 Imidazoline corrosion inhibitors |
| 01/25/2006 | EP1618099A2 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | EP1245232B1 Oral solid preparation |
| 01/25/2006 | CN1726211A Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| 01/25/2006 | CN1726200A Ionic liquids comprising [N(CF3)2] anions |
| 01/25/2006 | CN1238393C (Cyclo) condensation of isocyanate compounds |
| 01/25/2006 | CN1238338C Process for the preparation of 4(5)-amino-5(4) carboxamidoimidoimidazoles intermediates |
| 01/24/2006 | US6989402 Thyroid receptor ligands and method II |
| 01/24/2006 | US6989399 Antiamyloid phenylsulfonamides: N-alkanol derivatives |
| 01/24/2006 | US6989395 TNF inhibitors |